Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update

Front Neurol. 2021 Mar 29:12:630221. doi: 10.3389/fneur.2021.630221. eCollection 2021.

Abstract

Meige syndrome (MS) is cranial dystonia characterized by the combination of upper and lower cranial involvement and including binocular eyelid spasms (blepharospasm; BSP) and involuntary movements of the jaw muscles (oromandibular dystonia; OMD). The etiology and pathogenesis of this disorder of the extrapyramidal system are not well-understood. Neurologic and ophthalmic examinations often reveal no abnormalities, making diagnosis difficult and often resulting in misdiagnosis. A small proportion of patients have a family history of the disease, but to date no causative genes have been identified to date and no cure is available, although botulinum toxin A therapy effectively mitigates the symptoms and deep brain stimulation is gaining increasing attention as a viable alternative treatment option. Here we review the history and progress of research on MS, BSP, and OMD, as well as the etiology, pathology, diagnosis, and treatment.

Keywords: Meige syndrome; blepharospasm; oromandibular dystonia; pathogenic gene; variants.

Publication types

  • Review